Financial statement

Cairn Homes Plc: Replacement - Annual Report and Notice of AGM

Retrieved on: 
星期三, 四月 10, 2024

Dublin / London, 26 March 2024: Cairn Homes plc (“Cairn”, “the Company” or “the Group”), announces that its Annual Report for the year ended 31 December 2023, together with the Letter from the Chairman and 2024 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.

Key Points: 
  • Dublin / London, 26 March 2024: Cairn Homes plc (“Cairn”, “the Company” or “the Group”), announces that its Annual Report for the year ended 31 December 2023, together with the Letter from the Chairman and 2024 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.
  • The Annual General Meeting will be held on 10 May 2024 at 12:00 noon in The Merrion Hotel, Merrion Street Upper, Dublin 2, Ireland.
  • Copies of the above documents (including the Annual Report and Financial Statements for the year ended 31 December 2023 in ESEF compliant format) are also available on the Company's website, www.cairnhomes.com .
  • The Annual Report will also be submitted to the UK National Storage Mechanism and Euronext Dublin, and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and at the following address:

Cairn Homes Plc: Annual Report and Notice of Annual General Meeting

Retrieved on: 
星期三, 四月 10, 2024

Dublin / London, 26 March 2024: Cairn Homes plc (“Cairn”, “the Company” or “the Group”), announces that its Annual Report for the year ended 31 December 2023, together with the Letter from the Chairman and 2024 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.

Key Points: 
  • Dublin / London, 26 March 2024: Cairn Homes plc (“Cairn”, “the Company” or “the Group”), announces that its Annual Report for the year ended 31 December 2023, together with the Letter from the Chairman and 2024 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.
  • The Annual General Meeting will be held on 10 May 2023 at 12:00 noon in The Merrion Hotel, Merrion Street Upper, Dublin 2, Ireland.
  • Copies of the above documents (including the Annual Report and Financial Statements for the year ended 31 December 2023 in ESEF compliant format) are also available on the Company's website, www.cairnhomes.com .
  • The Annual Report will also be submitted to the UK National Storage Mechanism and Euronext Dublin, and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and at the following address:

Turkiye Garanti Bankasi A.S.: Information regarding the results of Ordinary General Shareholders' Meeting

Retrieved on: 
星期三, 四月 10, 2024

The meeting minutes, list of participants and the profit distribution table are attached hereto.

Key Points: 
  • The meeting minutes, list of participants and the profit distribution table are attached hereto.
  • (The meeting minutes and the profit distribution table are in Turkish and English, whereas the list of participants is in Turkish.)
  • *In contradiction between the Turkish and English versions of this public disclosure, the Turkish version shall prevail.
  • Contact Garanti BBVA Investor Relations:

RM plc: Publication of 2023 Annual Report and Financial Statements

Retrieved on: 
星期三, 四月 10, 2024

RM announces, in accordance with Listing Rules 9.6.1 and 9.6.3, that the Annual Report and Financial Statements for the year ended 30 November 2023 (the "Annual Report and Financial Statements 2023") have today been submitted to the Financial Conduct Authority via the National Storage Mechanism ("NSM"), where they will shortly be available for viewing at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

Key Points: 
  • RM announces, in accordance with Listing Rules 9.6.1 and 9.6.3, that the Annual Report and Financial Statements for the year ended 30 November 2023 (the "Annual Report and Financial Statements 2023") have today been submitted to the Financial Conduct Authority via the National Storage Mechanism ("NSM"), where they will shortly be available for viewing at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
  • In accordance with Disclosure Guidance and Transparency Rule ("DTR") 6.3.5R(1A), the regulated information required under DTR 6.3.5 is available in unedited full text within the Annual Report and Financial Statements 2023 as uploaded and available on the NSM and on the Company's website as noted above.
  • The date for the Company's 2024 Annual General Meeting (the "AGM") and the notice of AGM will be published on the Company's website and distributed to shareholders in due course.

EQS-News: SMA Group reports extraordinarily strong 2023

Retrieved on: 
星期三, 四月 10, 2024

EBIT climbed from €31.9 million in the 2022 fiscal year to €269.5 million (EBIT margin 2023: 14.2%; 2022: 3.0%).

Key Points: 
  • EBIT climbed from €31.9 million in the 2022 fiscal year to €269.5 million (EBIT margin 2023: 14.2%; 2022: 3.0%).
  • Inverter output sold in 2023 as a whole was 20.5 GW (2022: 12.2 GW).
  • A share of 2.0% was attributable to the Americas region (2022: 8.3%) and 1.1% to the APAC region (2022: 5.0%).
  • SMA published its audited Consolidated Financial Statements and the Annual Report for 2023 today and will explain the business development during a virtual press conference at 10:00 a.m. and a conference call for analysts and investors at 1:30 p.m.

7th Annual General Meeting: Shareholders approve all proposals

Retrieved on: 
星期三, 四月 10, 2024

The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern.

Key Points: 
  • The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern.
  • The shareholders approved all the proposals put forward by the Board of Directors.
  • The Annual General Meeting also approved the dividend at the prior-year level of CHF 2.20 per share proposed by the Board of Directors.
  • The dividend for the 2023 financial year will be paid to shareholders from 16 April 2024.

Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Retrieved on: 
星期二, 四月 2, 2024

"Cardiol Therapeutics made important progress in 2023 and early 2024 as we pursued our primary objective of providing new therapeutic options to patients with poorly served heart diseases," said David Elsley, President and Chief Executive Officer of Cardiol Therapeutics.

Key Points: 
  • "Cardiol Therapeutics made important progress in 2023 and early 2024 as we pursued our primary objective of providing new therapeutic options to patients with poorly served heart diseases," said David Elsley, President and Chief Executive Officer of Cardiol Therapeutics.
  • In January 2023, Cardiol announced the first patient had been enrolled in the Company's Phase II open-label pilot study ("MAvERIC-Pilot") investigating the tolerance, safety, and efficacy of CardiolRx™ in patients with recurrent pericarditis.
  • In November 2023, Cardiol announced that it had exceeded 50% of the patient enrollment target for the MAvERIC-Pilot study.
  • In January 2024, Cardiol announced that ARCHER had exceeded 50% patient enrollment and was progressing ahead of the original study timeline.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR

Retrieved on: 
星期一, 四月 8, 2024

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR).
  • The investigation concerns whether Lifecore and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Further, the 2023 10-K stated that “this determination resulted from the identification of errors in the Prior Financial Statements related to adjustments [.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

GOGL – Notice of 2024 Annual General Meeting

Retrieved on: 
星期五, 四月 5, 2024

Golden Ocean Group Limited (the “Company”) announces that its 2024 Annual General Meeting will be held on April 29, 2024.

Key Points: 
  • Golden Ocean Group Limited (the “Company”) announces that its 2024 Annual General Meeting will be held on April 29, 2024.
  • A copy of the Notice of Annual General Meeting and associated information including the Company`s Consolidated Financial Statements on Form 20-F for 2023 can be found on our website at www.goldenocean.bm and in the links below.
  • This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

PrairieSky Royalty Announces Conference Call for Q1 2024 Results

Retrieved on: 
星期四, 四月 4, 2024

CALGARY, Alberta, April 04, 2024 (GLOBE NEWSWIRE) -- PrairieSky will release its Q1 2024 results on Monday, April 22, 2024 after markets close.

Key Points: 
  • CALGARY, Alberta, April 04, 2024 (GLOBE NEWSWIRE) -- PrairieSky will release its Q1 2024 results on Monday, April 22, 2024 after markets close.
  • The news release detailing PrairieSky's Q1 2024 results will provide operating and financial information.
  • A conference call to discuss the results will be held for the investment community on Tuesday, April 23, 2023 beginning at 6:30 am MT (8:30 am ET).
  • To participate in the conference call, you are asked to register at the link provided below.